Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
17.41
-0.33 (-1.86%)
Dec 27, 2024, 4:00 PM EST - Market closed
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $616.41 million as of December 27, 2024. Its market cap has increased by 34.68% in one year.
Market Cap
616.41M
Enterprise Value
228.38M
1-Year Change
34.68%
Ranking
Category
Stock Price
$17.41
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $616.41M, an increase of 145.57%. That is a compound annual growth rate of 32.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 616.41M | 22.54% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRAIL | 639.70M |
| Capricor Therapeutics | 634.30M |
| Omeros | 633.68M |
| Pharming Group | 629.37M |
| Opthea | 628.19M |
| Varex Imaging | 610.66M |
| Arbutus Biopharma | 600.65M |
| Cross Country Healthcare | 591.18M |